Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 586-592 , December 2009

Recurrence pattern after [(18)F]Fluoroethyltyrosine-Positron Emission Tomography-guided radiotherapy for high-grade glioma: A prospective study

  • Damien C. Weber

      Affiliations

    • Department of Radiation Oncology, and
    • Department of Radiation Oncology, University of Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Geneva University Hospital, CH-1211 Geneva 14, Switzerland.
    • ,
  • Nathalie Casanova

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Thomas Zilli

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Franz Buchegger

      Affiliations

    • Department of Nuclear Medicine, Geneva University Hospital, Switzerland
    • ,
  • Michel Rouzaud

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Philippe Nouet

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Hansjorg Vees

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Osman Ratib

      Affiliations

    • Department of Nuclear Medicine, Geneva University Hospital, Switzerland
    • Department of Radiation Oncology, University of Geneva, Switzerland
    • ,
  • Giovanna Dipasquale

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Raymond Miralbell

      Affiliations

    • Department of Radiation Oncology, and
    • Department of Radiation Oncology, University of Geneva, Switzerland

Received 13 November 2008 ,Revised 21 August 2009 ,Accepted 30 August 2009.

References 

  1. Kato T, Shinoda J, Nakayama N, et al. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. Ajnr. 2008;29:1176–1182
  2. Estrada G, Gonzalez-Maya L, Celis-Lopez MA, et al. Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico. Rev Esp Med Nucl. 2008;27:329–339
  3. Floeth FW, Pauleit D, Sabel M, et al. Prognostic value of O-(2-18F-fluoroethyl)-l-tyrosine PET and MRI in low-grade glioma. J Nucl Med. 2007;48:519–527
  4. Pirotte BJ, Levivier M, Goldman S, et al. Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients. Neurosurgery. 2009;64:471–481discussion 481
  5. Charnley N, West CM, Barnett CM, et al. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:331–338
  6. Miwa K, Matsuo M, Shinoda J, et al. Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with (11)C-methionine PET: report of three cases. J Neurooncol. 2008;[Epub ahead of print]
  7. Mahasittiwat P, Mizoe JE, Hasegawa A, et al. l-[Methyl-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:515–522
  8. Grosu A-L, Weber WA, Riedel E, et al. l-(Methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:64–74
  9. Lee IH, Piert M, Gomez-Hassan D, et al. Association of (11)C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2008;
  10. Weber DC, Zilli T, Buchegger F, et al. [(18)F]Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma. Radiat Oncol (London, UK). 2008;3:44
  11. Vees H, Senthamizhchelvan S, Miralbell R, Weber DC, Ratib O, Zaidi H. Assessment of various strategies for (18)F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging. 2008;
  12. Chang EL, Akyurek S, Avalos T, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys. 2007;68:144–150
  13. Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol. 2002;20:1635–1642
  14. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol. 1994;30:146–149
  15. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol. 1999;53:53–57
  16. Wick W, Stupp R, Beule AC, et al. A novel tool to analyse MRI recurrence patterns in glioblastoma. Neuro-oncol. 2008;
  17. Mangiola A, de Bonis P, Maira G, et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme. Cancer. 2008;113:841–846
  18. Schiffer D, Cavalla P, Dutto A, Borsotti L. Cell proliferation and invasion in malignant gliomas. Anticancer Res. 1997;17:61–69
  19. Berens ME, Giese A. “...those left behind” Biology and oncology of invasive glioma cells. Neoplasia (New York, NY). 1999;1:208–219
  20. Cattaneo GM, Reni M, Rizzo G, et al. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiother Oncol. 2005;75:217–223

PII: S0167-8140(09)00495-2

doi: 10.1016/j.radonc.2009.08.043

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 586-592 , December 2009

Article Tools

* Image Usage & Resolution